Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Disruption of mutp53 stability might hold the key in this long and hard battle against Cancer

Is the pandemic interfering with the treatment for other diseases?

NEIGRIHMS Life Science Project Manager Recruitment | Applications Invited

Disruption of mutp53 stability might hold the key in this long and hard battle against Cancer
  • BiotechToday
  • World

Disruption of mutp53 stability might hold the key in this long and hard battle against Cancer

bioxone October 20, 2020October 19, 2020

Biswadeep Sen, Amity University Kolkata

Recent studies show that Inflammation and Carcinogenic processes are interconnected. Not just because both induce DNA instability, but both are driven by the same pathways (like NF-kB, STAT3, mTOR and MAPKs). 

The pro-inflammatory cytokines like IL-6, IL-1β, TNF-α and IL-10 mould our immune responses and they are controlled by the pathways mentioned above. Therefore, they can be considered as a double-edged sword, responsible for both our protection and if went wrong, or destruction.  Now, these pathways often trigger the UPR which is responsible for cells to survive stress and is initiated by three cellular sensors. These sensors can also trigger the oncogenic pathways leading to malignancy of tumours. UPR is activated whenever an unfolded protein finds itself inside the ER and via autophagy, it helps to eliminate the misfolded proteins. So, we can safely assume that any regulatory problem about it, might trigger a host of diseases including cancer. 

Studies have pointed out that ATF6, one of the three sensors of UPR, activated by a mutp53 May contribute to a p38 phosphorylation making it possible for counteracting the autophagy.   On the other hand, NF-KB, which is reported to inhibit autophagy, might also be activated by ARF6 and induced by a mutp53. This could contribute to its sustainability of expression level and inhibition of Autophagy. 

Therefore, interrupting such interplay between UPR and the oncogenic pathways may affect the pre oncogenic inflammation and stability of a mutp53 and downregulation of them might break the bridge between inflammation and cancer. Several Inhibitors like WP1066 or LY3007113 are used alone or in combination so that they can interfere with the aspects of carcinomic biology. 

Also read: Efficient and cost-effective Bacterial mRNA sequencing causing ribosomal RNA depletion

Source: D’Orazi, G., Cordani, M. & Cirone, M. Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: a clue for novel anticancer therapies. Cell. Mol. Life Sci. (2020). https://doi.org/10.1007/s00018-020-03677-7

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Autophagy Carcinogen DNA instability folding immunology inflammation inhibitor interleukins malignancy metastasis modulator oncogenic pathways oncology protein folding stereochemistry

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

NEIGRIHMS Life Science Project Manager Recruitment | Applications Invited

bioxone October 20, 2020

-Shristi Sharma, Team bioXone NEIGRIHMS Life Science Project Manager Recruitment – Applications Invited. NEIGRIHMS is recruiting for a project manager job. MSc Life Science candidates are encouraged to attend the walk-in interview that has been scheduled, check out all of the details on the same below: Keep in mind: Applicants who wish to appear in […]

Related Post

  • BiotechToday
  • World

Decontamination strategy for detection of cfmDNA in humans

bioxone June 26, 2021June 26, 2021

Madhavi Bhatia, NIPER Guwahati. The gut flora of humans acts as a major factor that influences the health of an individual. The microbiome may affect the disease progression and response to immunotherapy. So, the gut microbiome can act as a cancer biomarker. For analyzing this high throughput 16S-rRNA-gene-based approach is utilized to detect a genuine […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

AXL receptor: a new companion of the ACE2 receptor which helps SARS-CoV-2 to enter the human body

bioxone January 16, 2021January 16, 2021

Parnad Basu, Amity University Kolkata The pandemic caused by COVID-19 is continuing still. The causative viral pathogen of COVID-19 is SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). This SARS-CoV-2 actually belongs to the β coronavirus genus along with SARS-CoV (severe acute respiratory syndrome coronavirus) and MERS-CoV (middle east respiratory syndrome coronavirus). Although SARS-CoV-2 targets the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

COVID-19 vaccine in Immunocompromised individuals.

bioxone July 10, 2021July 9, 2021

Avani Dave, Jai Hind College A recent study conducted by Satveer Mahil et al., showcased in the current year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, demonstrates that it is not the response of T-cell but that of the antibody to the first jab of the Pfizer […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy